SPDR S&P Biotech Etf (Xbi) Shares Bought by David R. Rahn & Associates Inc.


David R. Rahn & Associates Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 11.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 20,624 shares of the exchange traded fund's stock after acquiring an additional 2,109 shares during the quarter.



from Biotech News